Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications
Toru Saeki Mima Yukihiko(Osaka Minami Medical Center), Ichiro Kawase(Osaka University), Shiro Ohshima, Hideki Asaoku(Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital), Naokazu Kinoshita(National Cerebral and Cardiovascular Center), Atsushi Ogata(High Energy Accelerator Research Organization), Yoshinori Katada(Osaka Minami Medical Center), Kazuyuki Yoshizaki(Osaka Research Institute of Industrial Science and Technology), Masayasu Kitano(Hyogo Medical University), Yuichiro Tabunoki(The University of Osaka), Norihiro Nishimoto(Wakayama Medical University), Tetsushi Ishida(The University of Osaka), T Uede(Hokkaido University), Masao Mizuki(The University of Osaka), Masahiro Maeda(Medical & Biological Laboratories (Japan)), Taeko Ishii(Eli Lilly (Japan)), Hideyuki Kobayashi(University of Occupational and Environmental Health Japan), Hitoshi Kitayama(Fukushima Medical University), Shigeyuki Kon(Hokkaido University)
Cited by 66
Related Papers
The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis
|Cell|2001|715
Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique
|Journal of the American College of Cardiology|1986|573
Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK
|Proceedings of the National Academy of Sciences|1998|492